Tag - medicine

 
Menu
Search
 
July 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE

Japan Times
JAPAN / Science & Health
Jun 20, 2021
The Japanese scientist fighting prejudice, misinformation and COVID-19
Akiko Iwasaki is leading a team of immunologists hoping to beat 'long COVID-19' while also debunking myths surrounding the coronavirus.
Japan Times
JAPAN / Science & Health
Jun 20, 2021
New Japan law lays bare hardships of children needing daily medical care
The number of children age under 20 who need daily medical care is estimated to total some 20,000, and getting places in education remains difficult.
Japan Times
WORLD / Science & Health
Jun 16, 2021
Regeneron drug reduces COVID-19 patient deaths in large study
The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company's casirivimab and imdevimab combination of monoclonal antibodies.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
ASIA PACIFIC
Jun 11, 2021
Indians still battling impacts of COVID-19 now burdened with medical debt
Even before the pandemic struck, India's out-of-pocket expenses on health care were among the highest in the world.
Japan Times
COMMENTARY / World
Jun 10, 2021
Fixing the broken pandemic financing system
The devastation caused by COVID-19 has underscored what experts have said for years: our national, regional and global systems are grossly inadequate for detecting and containing outbreaks.
Japan Times
BUSINESS
Jun 9, 2021
Eisai sees potential of new Alzheimer's drug but costs remain concern
The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
COMMENTARY / World
Jun 7, 2021
The world should learn from India’s COVID-19 cataclysm
Strategies that kept the pandemic at bay in 2020 won't necessarily work in 2021.
Japan Times
COMMENTARY / World
Jun 6, 2021
Lessons from the pandemic
Most countries are lagging far behind and new, concerted and more generous efforts by the richest nations are needed to control the pandemic at a global level.
Japan Times
JAPAN / FOCUS
Jun 4, 2021
In Japan, the light at the end of the pandemic's tunnel remains distant
The vaccine rollout may be accelerating, but the nation remains far away from a return to normalcy.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
Japan Times
JAPAN / Science & Health
Jun 3, 2021
Japan to prioritize students heading abroad for COVID-19 vaccinations
The move comes as some schools in countries such as the United States have adopted requirements for students to be inoculated before they are allowed to participate in in-person classes.
Japan Times
JAPAN / Science & Health
Jun 3, 2021
Japan pledges $800 million for global COVID-19 vaccination effort
The COVAX Facility has beaten its goal of raising $8.3 billion to secure 1.8 billion doses, enough for 30% of the population of developing countries, Prime Minister Yoshihide Suga said.
Japan Times
JAPAN / Science & Health
May 30, 2021
COVID-19 vaccines to be available to all under 65 in Japan at same time
The central government is also considering administering U.S. pharmaceutical company Moderna Inc.'s vaccine, which was approved in Japan in May.
Japan Times
WORLD / Science & Health
May 28, 2021
AstraZeneca clot research continues amid German theory
German researchers said this week they discovered a link between the vaccine and rare blood clots.
Japan Times
WORLD / Science & Health
May 27, 2021
Immunity to the coronavirus may persist for years, scientists find
The findings may help put to rest lingering fears that protection against the virus will be short-lived.
Japan Times
COMMENTARY / World
May 26, 2021
Our responsibility to South Asia
Beyond inflicting agony on the sick, the coronavirus outbreak in the world's most populous democracy is now robbing victims of their dignity in death, too.
Who needs AI when you have Hatsune Miku?
Over the first six months of 2024, a handful of songs using Vocaloid singer Hatsune Miku’s voice have enjoyed widespread attention, underlining a global interest in the character and the technology she represents.
Yen’s woes seem too big for even a BOJ hike this month to solve
The Bank of Japan headquarters in Tokyo
China’s economic growth comes in worse than expected
Pedestrians in the Wangfujing shopping area in Beijing on July 11, 2024. China's economic growth in the second quarter was lower than forecast, adding pressure on Chinese leaders to lift confidence at the Chinese Communist Party's third plenum this week.
Kansai airports to increase takeoff and landing slots ahead of Osaka Expo
Kansai International Airport in Izumisano, Osaka Prefecture. The upper limit on the number of takeoff and landing slots at the airport as well as Kobe Airport in Hyogo Prefecture will be raised in spring next year ahead of the 2025 World Exposition in Osaka.
Shooter came within inches of killing Trump, but left few clues as to why
An aerial view shows the stage where Republican presidential candidate and former U.S. President Donald Trump had been standing during an assassination attempt the day before, and the roof of a nearby building where a gunman was shot dead by law enforcement, in Butler, Pennsylvania, on Sunday.
The neurological disorder that 'kills culture'
Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
After Trump shooting, U.S. presidential race might take a violent turn
United States Secret Service Counter Snipers stand guard on a rooftop during a campaign rally for U.S. President Donald Trump in Avoca, Pennsylvania, in 2020.
No AC this summer? No problem (for me).
Think air conditioning is a requirement for a Tokyo summer? Think again.
She’s paying ¥1 million to help behind the scenes at the Paris Olympics
Mai Tarumi, who previously volunteered at the postponed Tokyo Olympics in 2021, has a travel budget of ¥1 million for her trip to volunteer at the Paris Games.

Podcast

You can often see generations of families enjoying performances together at Fuji Rock Festival.
Japan’s summer music festivals are feeling the heat in more ways than one

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'
By Tomoko Otake

SUSTAINABLE JAPAN

Festival overcomes a nuclear accident and COVID
Festival overcomes a nuclear accident and COVID

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER